Ignite Creation Date:
2024-05-06 @ 7:57 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06199882
Status:
SUSPENDED
Last Update Posted:
2024-01-10
First Post:
2023-12-29
Brief Title:
SBRT Sequential Surufatinib Combined With Immunotherapy for Biliary Tract Carcinoma
Sponsor:
Organization:
Zhejiang Cancer Hospital